189 related articles for article (PubMed ID: 32385243)
21. Autophagy induced by AXL receptor tyrosine kinase alleviates acute liver injury via inhibition of NLRP3 inflammasome activation in mice.
Han J; Bae J; Choi CY; Choi SP; Kang HS; Jo EK; Park J; Lee YS; Moon HS; Park CG; Lee MS; Chun T
Autophagy; 2016 Dec; 12(12):2326-2343. PubMed ID: 27780404
[TBL] [Abstract][Full Text] [Related]
22. The crosstalk between AXL and YAP promotes tumor progression through STAT3 activation in head and neck squamous cell carcinoma.
Li J; Shi C; Zhou R; Han Y; Xu S; Ma H; Zhang Z
Cancer Sci; 2020 Sep; 111(9):3222-3235. PubMed ID: 32589311
[TBL] [Abstract][Full Text] [Related]
23. Novel Axl-driven signaling pathway and molecular signature characterize high-grade ovarian cancer patients with poor clinical outcome.
Rea K; Pinciroli P; Sensi M; Alciato F; Bisaro B; Lozneanu L; Raspagliesi F; Centritto F; Cabodi S; Defilippi P; Avanzi GC; Canevari S; Tomassetti A
Oncotarget; 2015 Oct; 6(31):30859-75. PubMed ID: 26356564
[TBL] [Abstract][Full Text] [Related]
24. Effects of Gas6 and hydrogen peroxide in Axl ubiquitination and downregulation.
Valverde P
Biochem Biophys Res Commun; 2005 Jul; 333(1):180-5. PubMed ID: 15958209
[TBL] [Abstract][Full Text] [Related]
25. Activation of HER3 interferes with antitumor effects of Axl receptor tyrosine kinase inhibitors: suggestion of combination therapy.
Torka R; Pénzes K; Gusenbauer S; Baumann C; Szabadkai I; Őrfi L; Kéri G; Ullrich A
Neoplasia; 2014 Apr; 16(4):301-18. PubMed ID: 24862757
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of IL-6/STAT3 axis and targeting Axl and Tyro3 receptor tyrosine kinases by apigenin circumvent taxol resistance in ovarian cancer cells.
Suh YA; Jo SY; Lee HY; Lee C
Int J Oncol; 2015 Mar; 46(3):1405-11. PubMed ID: 25544427
[TBL] [Abstract][Full Text] [Related]
27. Qigesan reduces the motility of esophageal cancer cells via inhibiting Gas6/Axl and NF-κB expression.
Kong L; Wu Z; Zhao Y; Lu X; Shi H; Liu S; Li J
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31110076
[TBL] [Abstract][Full Text] [Related]
28. Anexelekto (AXL) Increases Resistance to EGFR-TKI and Activation of AKT and ERK1/2 in Non-Small Cell Lung Cancer Cells.
Tian Y; Zhang Z; Miao L; Yang Z; Yang J; Wang Y; Qian D; Cai H; Wang Y
Oncol Res; 2016; 24(5):295-303. PubMed ID: 27712586
[TBL] [Abstract][Full Text] [Related]
29. CBL controls a tyrosine kinase network involving AXL, SYK and LYN in nilotinib-resistant chronic myeloid leukaemia.
Gioia R; Trégoat C; Dumas PY; Lagarde V; Prouzet-Mauléon V; Desplat V; Sirvent A; Praloran V; Lippert E; Villacreces A; Leconet W; Robert B; Vigon I; Roche S; Mahon FX; Pasquet JM
J Pathol; 2015 Sep; 237(1):14-24. PubMed ID: 25965880
[TBL] [Abstract][Full Text] [Related]
30. The GAS6-AXL signaling network is a mesenchymal (Mes) molecular subtype-specific therapeutic target for ovarian cancer.
Antony J; Tan TZ; Kelly Z; Low J; Choolani M; Recchi C; Gabra H; Thiery JP; Huang RY
Sci Signal; 2016 Oct; 9(448):ra97. PubMed ID: 27703030
[TBL] [Abstract][Full Text] [Related]
31. HGF-induced formation of the MET-AXL-ELMO2-DOCK180 complex promotes RAC1 activation, receptor clustering, and cancer cell migration and invasion.
Li W; Xiong X; Abdalla A; Alejo S; Zhu L; Lu F; Sun H
J Biol Chem; 2018 Oct; 293(40):15397-15418. PubMed ID: 30108175
[TBL] [Abstract][Full Text] [Related]
32. Lactate engages receptor tyrosine kinases Axl, Tie2, and vascular endothelial growth factor receptor 2 to activate phosphoinositide 3-kinase/Akt and promote angiogenesis.
Ruan GX; Kazlauskas A
J Biol Chem; 2013 Jul; 288(29):21161-21172. PubMed ID: 23754286
[TBL] [Abstract][Full Text] [Related]
33. Gas6-axl receptor signaling is regulated by glucose in vascular smooth muscle cells.
Cavet ME; Smolock EM; Ozturk OH; World C; Pang J; Konishi A; Berk BC
Arterioscler Thromb Vasc Biol; 2008 May; 28(5):886-91. PubMed ID: 18292389
[TBL] [Abstract][Full Text] [Related]
34. Gas6/Axl-PI3K/Akt pathway plays a central role in the effect of statins on inorganic phosphate-induced calcification of vascular smooth muscle cells.
Son BK; Kozaki K; Iijima K; Eto M; Nakano T; Akishita M; Ouchi Y
Eur J Pharmacol; 2007 Feb; 556(1-3):1-8. PubMed ID: 17196959
[TBL] [Abstract][Full Text] [Related]
35. p85β alters response to EGFR inhibitor in ovarian cancer through p38 MAPK-mediated regulation of DNA repair.
Mak VC; Li X; Rao L; Zhou Y; Tsao SW; Cheung LW
Neoplasia; 2021 Jul; 23(7):718-730. PubMed ID: 34144267
[TBL] [Abstract][Full Text] [Related]
36. Cilostazol inhibits uremic toxin-induced vascular smooth muscle cell dysfunction: role of Axl signaling.
Lee CH; Hung YJ; Shieh YS; Chien CY; Hsu YJ; Lin CY; Chiang CF; Huang CL; Hsieh CH
Am J Physiol Renal Physiol; 2017 Mar; 312(3):F398-F406. PubMed ID: 27927649
[TBL] [Abstract][Full Text] [Related]
37. Role of the Receptor Tyrosine Kinase Axl and its Targeting in Cancer Cells.
Corno C; Gatti L; Lanzi C; Zaffaroni N; Colombo D; Perego P
Curr Med Chem; 2016; 23(15):1496-512. PubMed ID: 27048336
[TBL] [Abstract][Full Text] [Related]
38. FER-mediated phosphorylation and PIK3R2 recruitment on IRS4 promotes AKT activation and tumorigenesis in ovarian cancer cells.
Zhang Y; Xiong X; Zhu Q; Zhang J; Chen S; Wang Y; Cao J; Chen L; Hou L; Zhao X; Hao P; Chen J; Zhuang M; Li D; Fan G
Elife; 2022 May; 11():. PubMed ID: 35550247
[TBL] [Abstract][Full Text] [Related]
39. AXL-Driven EMT State as a Targetable Conduit in Cancer.
Antony J; Huang RY
Cancer Res; 2017 Jul; 77(14):3725-3732. PubMed ID: 28667075
[TBL] [Abstract][Full Text] [Related]
40. Newly Identified Members of FGFR1 Splice Variants Engage in Cross-talk with AXL/AKT Axis in Salivary Adenoid Cystic Carcinoma.
Humtsoe JO; Kim HS; Leonard B; Ling S; Keam B; Marchionni L; Afsari B; Considine M; Favorov AV; Fertig EJ; Kang H; Ha PK
Cancer Res; 2021 Feb; 81(4):1001-1013. PubMed ID: 33408119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
